These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5011607)

  • 1. [Disappearance rate of bacteria as a parameter of the efficacy of tuberculostatic treatment of cavitating lung tuberculosis].
    Seri I
    Prax Pneumol; 1972 Jan; 26(1):12-22. PubMed ID: 5011607
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract]   [Full Text] [Related]  

  • 3. [The rate of destruction of sensitive mycobacteria as a factor in the development of resistance in cavitating pulmonary tuberculosis].
    Seri I
    Prax Pneumol; 1974 May; 28(5):256-62. PubMed ID: 4210051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dynamics of the excretion of the bacilli in patients with destructive pulmonary tuberculosis under the effect of long-term tuberculostatic therapy].
    Fisher EF; Velichko SA; Sharaburova OE; Strelis AK
    Lab Delo; 1973; 6():340-2. PubMed ID: 4129386
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of casual isolation of acid-fast organisms from sputum of tuberculous patients.
    Tsukamura M
    Am Rev Respir Dis; 1973 Dec; 108(6):1429-30. PubMed ID: 4201631
    [No Abstract]   [Full Text] [Related]  

  • 6. Modern short-course regimens in the treatment of tuberculosis.
    Fox W
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
    [No Abstract]   [Full Text] [Related]  

  • 7. Some remarks on the recent bacteriological research on tuberculosis.
    Daddi G; Lucchesi M; Zubiani M
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):164-9. PubMed ID: 7166352
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endocavernous treatment of caverns with atypical Mycobacteria].
    Neef W
    Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837
    [No Abstract]   [Full Text] [Related]  

  • 9. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possibility of the intensification of tuberculosis chemotherapy and its limits].
    Naito M; Kanai K; Kondo E; Yamashita H; Matsui K
    Kekkaku; 1969 Nov; 44(11):377-93. PubMed ID: 4982567
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 12. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens.
    Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR
    Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities of negative sputum culture following treatment with 3 combinations of antitubercular agents].
    Sutalo I
    Tuberkuloza; 1965; 17(4):317-23. PubMed ID: 5871208
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conversion of the sputum--only a relative success measurement in the treatment of tuberculosis. Bacteriological study of 614 resection preparations].
    Winter G; Viereck HJ
    Med Welt; 1972 Sep; 23(38):1294-7. PubMed ID: 5078662
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and management of tuberculosis.
    Harris AA; Karakusis P
    Prim Care; 1979 Mar; 6(1):43-62. PubMed ID: 111269
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of adequate drug combinations in the treatment of cavernous tuberculosis].
    Seri I
    Prax Pneumol; 1971 Apr; 25(4):211-9. PubMed ID: 4995326
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of directed bronchial secretion aspiration for the bacteriological diagnosis of tuberculosis].
    Ewert EG
    Z Tuberk Erkr Thoraxorg; 1967; 126(3):162-8. PubMed ID: 4971151
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term treatment of tuberculosis with isoprodian (author's transl)].
    Bergsmann O; Spielmann E
    Wien Klin Wochenschr; 1979 Aug; 91(15):513-6. PubMed ID: 473771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation of atypical Mycobacteria from the patients with tuberculosis and methods of their primary identification].
    Mikhaĭlova LV
    Sov Zdravookhr Kirg; 1973; 4():53-5. PubMed ID: 4207845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.